AMARIN UK LIMITED

13014219
Active London

Wholesale of pharmaceutical goods

39 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
A

AMARIN UK LIMITED

13014219

Wholesale of pharmaceutical goods

Founded 12 Nov 2020 Active London, United Kingdom 39 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
Accounts Submitted 24 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 4 Dec 2025 Next due 25 Nov 2026 5 months remaining
Net assets £280K £62K 2024 year on year
Total assets £2M £322K 2024 year on year
Total Liabilities £2M £260K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Tmf Group 13th Floor One Angel Court London EC2R 7HJ United Kingdom

Website

www.example.com

Full company profile for AMARIN UK LIMITED (13014219), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 12 Nov 2020. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type audit-exemption-subsidiary
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2021–2024)

Cash in Bank

£340.69k

Increased by £90.69k (+36%)

Net Assets

£280.24k

Increased by £62.09k (+28%)

Total Liabilities

£1.62M

Increased by £260.05k (+19%)

Turnover

£10.57M

Increased by £819.32k (+8%)

Employees

39

Decreased by 6 (-13%)

Debt Ratio

85%

Decreased by 1 (-1%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Christine TeinturierDirectorFrench,britishFrance6125 Sept 2023Active

Shareholders

Shareholders (1)

Amarin Pharmaceuticals Ireland Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Amarin Corp

United States Of America

Active
Notified 12 Nov 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

AMARIN UK LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Dec 2025Confirmation StatementConfirmation statement made on 11 Nov 2025 with no updates
24 Sept 2025AccountsAnnual accounts filed
24 Sept 2025OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/24
24 Sept 2025OtherAudit exemption statement of guarantee by parent company for period ending 31/12/24
24 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
4 Dec 2025 Confirmation Statement

Confirmation statement made on 11 Nov 2025 with no updates

24 Sept 2025 Accounts

Annual accounts filed

24 Sept 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

24 Sept 2025 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/24

24 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Confirmation statement made on 11 Nov 2025 with no updates

6 months ago on 4 Dec 2025

Annual accounts filed

8 months ago on 24 Sept 2025

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

8 months ago on 24 Sept 2025

Audit exemption statement of guarantee by parent company for period ending 31/12/24

8 months ago on 24 Sept 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 24 Sept 2025